Author

Elise Joëlle Smolders

Observed names: E J Smolders, E. J. Smolders, E. Smolders, E.J. Smolders, EJ Smolders, Elise J Smolders, Elise J. Smolders, Elise Joelle Smolders, Elise Smolders

Institution: Isala

Observed institutions: Radboud University Nijmegen, University of Groningen, Radboud University Medical Center, University Medical Center Utrecht, Ospedale Amedeo di Savoia, Isala, Radboud Institute for Health Sciences, University of Colorado Anschutz, University of Turin

ORCID: 0000-0001-5694-9758

Observed ORCID: 0000-0001-5694-9758

OpenAlex ID: A5010097591

Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects

2019 · Ekta Lachmandas, Clare Eckold, et al. · The Journal of Infectious Diseases · 121

PDF

Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update

2019 · Elise J. Smolders, Anouk M. E. Jansen, et al. · Clinical Pharmacokinetics · 83

PDF

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment

2016 · Elise J. Smolders, Clara T. M. M. de Kanter, et al. · Drug Safety · 75

PDF

Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

2020 · Fiona Marra, Elise J. Smolders, et al. · Drugs in R&D · 50

PDF

Prospective validation of a model‐informed precision dosing tool for vancomycin in intensive care patients

2020 · Rob ter Heine, Ron J. Keizer, et al. · British Journal of Clinical Pharmacology · 46

PDF

The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview

2022 · Eline L Giraud, Kaylee R M Ferrier, et al. · The Lancet Oncology · 42

Review article: clinical pharmacology of current and investigational hepatitis B virus therapies

2019 · Elise J. Smolders, David M. Burger, et al. · Alimentary Pharmacology & Therapeutics · 42

Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands

2013 · Gwenny MPJ Verstappen, Elise J Smolders, et al. · BMC Public Health · 39

PDF

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

2016 · E. J. Smolders, C. T. M. M. de Kanter, et al. · Clinical Pharmacokinetics · 31

PDF

The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug‐drug interactions

2016 · Elise J Smolders, Floor AC Berden, et al. · United European Gastroenterology Journal · 29

PDF

Cardiovascular Risk Management and Hepatitis C: Combining Drugs

2018 · Elise J. Smolders, Peter J. G. ter Horst, et al. · Clinical Pharmacokinetics · 23

PDF

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?

2017 · E.J. Smolders, S. Pape, et al. · International Journal of Antimicrobial Agents · 21

Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring

2018 · Minou van Seyen, Elise J. Smolders, et al. · Journal of Hepatology · 18

PDF

An update on extravasation: basic knowledge for clinical pharmacists

2020 · Elise Joelle Smolders, Guillemette Emma Benoist, et al. · European Journal of Hospital Pharmacy · 16

PDF

Pharmacokinetics of Oral Tenofovir Disoproxil Fumarate in Pregnancy and Lactation: A Systematic Review

2018 · Marieke Bierhoff, Elise J Smolders, et al. · Antiviral Therapy · 16

Article Commentary: SARS-CoV-2 and HIV Protease Inhibitors: Why Lopinavir/Ritonavir will not Work for COVID-19 Infection

2019 · Elise J Smolders, Lindsey HM te Brake, et al. · Antiviral Therapy · 12

PDF

Management of drug interactions with direct‐acting antivirals in Dutch HIV /hepatitis C virus‐coinfected patients: adequate but not perfect

2017 · EJ Smolders, C Smit, et al. · HIV Medicine · 12

PDF

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine

2016 · E.J. Smolders, C.T.M.M. de Kanter, et al. · International Journal of Antimicrobial Agents · 12

Metformin and daclatasvir: absence of a pharmacokinetic–pharmacodynamic drug interaction in healthy volunteers

2017 · Elise J. Smolders, Angela Colbers, et al. · British Journal of Clinical Pharmacology · 9

PDF

What the Product Label Does Not Tell You About Drug–Drug Interaction Management

2023 · David M. Burger, Marianne le Comte, et al. · The Journal of Clinical Pharmacology · 8

Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat

2016 · E. J. Smolders, E. P. H. Colbers, et al. · Journal of Antimicrobial Chemotherapy · 8

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy

2020 · Vera E. Bukkems, Elise J. Smolders, et al. · The Journal of Clinical Pharmacology · 7

PDF

Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients

2017 · Elise J. Smolders, Colette Smit, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 7

Meropenem to Treat Valproic Acid Intoxication

2022 · Elise J. Smolders, Rob Ter Heine, et al. · Therapeutic Drug Monitoring · 6

A Call for a Consortium for Optimal Management of Drug–Drug Interactions in Patient Care

2017 · DM Burger, EJ Smolders, et al. · Clinical Pharmacology & Therapeutics · 6

Works count: 49

Citation count: 774

H-index: 15

I10-index: 18